Abstract:The CRISPR-Cas system holds great promise in the treatment of diseases caused by genetic variations. As wildtype SpyCas9 is known to generate many off-target effects, its use in the clinic remains controversial due to safety concerns. Several high-fidelity Cas9 variants with greater specificity have been developed using rational design and directed evolution. However, the enhancement of specificity by these methods is limited by factors like selection pressure and library diversity. Thus, in-silico protein engineering may provide a more efficient route for enhancing specificity, although computationally testing these proteins remains challenging. We recently demonstrated the advantage of normal mode analysis to simulate and predict the enzymatic function of SpyCas9 in the presence of mismatches. Here, we report several mathematical models describing the entropy and functionality relationships in the CRISPR-Cas9 system. We demonstrate the invariant characteristics of these models across different conformational structures. Based on these invariant models, we developed ComPE, a novel computational protein engineering method to modify the protein and measure the vibrational entropy of wildtype or variant SpyCas9 in complex with its sgRNA and target DNA. Using this platform, we discovered novel high-fidelity Cas9 variants with improved specificity. We functionally validated the improved specificity of four variants, and the intact on-target activity in one of them. Lastly, we demonstrate their reduced off-target editing and non-specific gRNA-independent DNA damage, highlighting their advantages for clinical applications. The described method could be applied to a wide range of proteins, from CRISPR-Cas orthologs to distinct proteins in any field where engineered proteins can improve biological processes.

Super-precise CRISPR tool enhanced by enzyme engineering

SgRNA Engineering for Improved Genome Editing and Expanded Functional Assays.

Scientists sharpen their molecular scissors and expand the gene editing toolbox

Improved genome editing by an engineered CRISPR-Cas12a

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

Computationally guided high-throughput engineering of an anti-CRISPR protein for precise genome editing in human cells

Rationally engineered Cas9 nucleases with improved specificity

Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants

Dissecting the mechanism of CRISPR–Cas technologies to design efficient biotechnologies

Harnessing noncanonical crRNA for highly efficient genome editing

To Cut or Not to Cut: Next-generation Genome Editors for Precision Genome Engineering

A cell cycle-dependent CRISPR-Cas9 activation system based on an anti-CRISPR protein shows improved genome editing accuracy

Advanced CRISPR system fixes a deadly mutation in cells

New advances in CRISPR/Cas-mediated precise gene-editing techniques

Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering

Machine learning-coupled combinatorial mutagenesis enables resource-efficient engineering of CRISPR-Cas9 genome editor activities

Engineered CRISPR-Cas9 nucleases with altered PAM specificities

Computationally Engineered CRISPR-SpyCas9 High-Fidelity Variants with Improved Specificity and Reduced Non-specific DNA Damage

Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity